FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4304127799> ?p ?o ?g. }

• W4304127799 endingPage "122274" @default.
• W4304127799 startingPage "122274" @default.
• W4304127799 abstract "The utilization of the proper and safe analgesics was considered a major concern in pain alleviation especially that associated with surgical procedures. Novel analgesics as Tapentadol hydrochloride (TAP) was involved efficiently instead of the common opioids to overcome the subsequent severe and common adverse effects associated with opioids utilization. Unfortunately, the extensive first pass metabolism limits the oral bioavailability of TAP and predisposes to a diminished duration of action, hence larger frequent doses of TAP will be required. Therefore, the target of this study was to lodge TAP into PEGylated transferosomes to boost its transdermal delivery. The PEGylation contemplated to boost both TAP permeability and bioavailability besides offering extra resilience to the vesicles. The impact of diverse variables on the characteristics of the vesicles and distinguishing the optimal formula were implemented adopting 23 factorial experiment via Design Expert® software. The resulted eight formulae were fabricated by thin film hydration technique, additionally they were evaluated based on the findings of entrapment efficiency percent (EE%), particle size (PS), polydispersity index (PDI), zeta potential (ZP) and the optimal one was involved in further assessments. The optimal formula (F8) exhibited spherical vesicles with EE% of 77.9 ± 3.4 %, PS of 150.5 ± 5.33 nm, PDI of 0.47 ± 0.05, ZP of −40.7 ± 4.6 mV and it also revealed greater deformability index (30.9 ± 6.1 g) relative to traditional transferosomes (12.15 ± 2.49 g). In addition, confocal laser scanning microscopy examination affirmed the superior penetration of Rhodamine B (RhB) dye thorough the rat's skin from F8 relative to the dye solution. The safety of F8 was confirmed by histopathological study. Moreover, dermato-kinetic study disclosed that TAP exhibited higher retention within the rat's skin form F8 relative to TAP dispersion. Furthermore, the in vivo pharmacodynamics activities conducted on male rats confirmed the superiority of F8 over the drug dispersion in alleviation the induced pain by IP injection of acetic acid and by formation of paw incisions. Collectively, the credibility of F8 as panel for transdermal delivery of TAP with boosted bioavailability and analgesic activity could be ensured on the basis of the obtained findings." @default.
• W4304127799 created "2022-10-11" @default.
• W4304127799 creator A5023014989 @default.
• W4304127799 creator A5035679368 @default.
• W4304127799 creator A5038402526 @default.
• W4304127799 creator A5043530064 @default.
• W4304127799 creator A5087866154 @default.
• W4304127799 date "2022-11-01" @default.
• W4304127799 modified "2023-10-16" @default.
• W4304127799 title "“Employment of PEGylated ultra-deformable transferosomes for transdermal delivery of tapentadol with boosted bioavailability and analgesic activity in post-surgical pain”" @default.
• W4304127799 cites W1966952912 @default.
• W4304127799 cites W1983223375 @default.
• W4304127799 cites W1987078254 @default.
• W4304127799 cites W1999408043 @default.
• W4304127799 cites W2017288717 @default.
• W4304127799 cites W2018761941 @default.
• W4304127799 cites W2018785523 @default.
• W4304127799 cites W2026519602 @default.
• W4304127799 cites W2028861639 @default.
• W4304127799 cites W2047405247 @default.
• W4304127799 cites W2049086737 @default.
• W4304127799 cites W2059166844 @default.
• W4304127799 cites W2064440136 @default.
• W4304127799 cites W2069516100 @default.
• W4304127799 cites W2072968157 @default.
• W4304127799 cites W2081241211 @default.
• W4304127799 cites W2086889742 @default.
• W4304127799 cites W2092161257 @default.
• W4304127799 cites W2092595668 @default.
• W4304127799 cites W2097652528 @default.
• W4304127799 cites W2101618387 @default.
• W4304127799 cites W2102432127 @default.
• W4304127799 cites W2117092024 @default.
• W4304127799 cites W2119223808 @default.
• W4304127799 cites W2121762824 @default.
• W4304127799 cites W2127884387 @default.
• W4304127799 cites W2161034880 @default.
• W4304127799 cites W2163468713 @default.
• W4304127799 cites W2167597191 @default.
• W4304127799 cites W2172201406 @default.
• W4304127799 cites W2488329304 @default.
• W4304127799 cites W2508207342 @default.
• W4304127799 cites W2586474778 @default.
• W4304127799 cites W2743986386 @default.
• W4304127799 cites W2790092507 @default.
• W4304127799 cites W2794170219 @default.
• W4304127799 cites W2794568335 @default.
• W4304127799 cites W2794612623 @default.
• W4304127799 cites W2795840512 @default.
• W4304127799 cites W2913945282 @default.
• W4304127799 cites W2950977232 @default.
• W4304127799 cites W2967089531 @default.
• W4304127799 cites W3016322511 @default.
• W4304127799 cites W3137055941 @default.
• W4304127799 cites W3166272851 @default.
• W4304127799 cites W3202315811 @default.
• W4304127799 cites W4220753601 @default.
• W4304127799 cites W4224325436 @default.
• W4304127799 cites W4229048538 @default.
• W4304127799 doi "https://doi.org/10.1016/j.ijpharm.2022.122274" @default.
• W4304127799 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36228884" @default.
• W4304127799 hasPublicationYear "2022" @default.
• W4304127799 type Work @default.
• W4304127799 citedByCount "8" @default.
• W4304127799 countsByYear W43041277992023 @default.
• W4304127799 crossrefType "journal-article" @default.
• W4304127799 hasAuthorship W4304127799A5023014989 @default.
• W4304127799 hasAuthorship W4304127799A5035679368 @default.
• W4304127799 hasAuthorship W4304127799A5038402526 @default.
• W4304127799 hasAuthorship W4304127799A5043530064 @default.
• W4304127799 hasAuthorship W4304127799A5087866154 @default.
• W4304127799 hasConcept C126322002 @default.
• W4304127799 hasConcept C170493617 @default.
• W4304127799 hasConcept C181389837 @default.
• W4304127799 hasConcept C185592680 @default.
• W4304127799 hasConcept C205679159 @default.
• W4304127799 hasConcept C2780505013 @default.
• W4304127799 hasConcept C2780820201 @default.
• W4304127799 hasConcept C2781063702 @default.
• W4304127799 hasConcept C42404028 @default.
• W4304127799 hasConcept C71924100 @default.
• W4304127799 hasConcept C98274493 @default.
• W4304127799 hasConceptScore W4304127799C126322002 @default.
• W4304127799 hasConceptScore W4304127799C170493617 @default.
• W4304127799 hasConceptScore W4304127799C181389837 @default.
• W4304127799 hasConceptScore W4304127799C185592680 @default.
• W4304127799 hasConceptScore W4304127799C205679159 @default.
• W4304127799 hasConceptScore W4304127799C2780505013 @default.
• W4304127799 hasConceptScore W4304127799C2780820201 @default.
• W4304127799 hasConceptScore W4304127799C2781063702 @default.
• W4304127799 hasConceptScore W4304127799C42404028 @default.
• W4304127799 hasConceptScore W4304127799C71924100 @default.
• W4304127799 hasConceptScore W4304127799C98274493 @default.
• W4304127799 hasLocation W43041277991 @default.
• W4304127799 hasLocation W43041277992 @default.
• W4304127799 hasOpenAccess W4304127799 @default.
• W4304127799 hasPrimaryLocation W43041277991 @default.
• W4304127799 hasRelatedWork W2282597098 @default.

• next